Updated:
Molecule Ventures
Molecule Ventures is a portfolio management services company founded in 2020 in Surat, India. It manages investments in mid- and small-cap companies.
Molecule Ventures
Molecule Ventures is a portfolio management services company founded in 2020 in Surat, India. It manages investments in mid- and small-cap companies. The firm offers medium- to long-term investments in companies with growth potential.
General information
Firm type
Venture Capital
Year founded
2020
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
Nik
Founder (inferred)
Nick
Firm and Fund Operations Lead
Gary Claar
Strategic Advisor
Grant
Lead, European Carbon Markets Research
Sector focus
Frequently asked questions
Who makes investment decisions at Molecule Ventures?
Nik leads strategic vision and market-direction calls, leveraging two decades of asset management experience including a partnership at JANA Partners and a senior fellowship at the Environmental Defense Fund. The firm also relies on dedicated research leads for European and global carbon markets — Grant and Jason — who model supply-demand fundamentals. Gary Claar advises on strategic risk, drawing on his own background as founding partner at JANA.
Is Molecule Ventures investing in companies or just trading carbon allowances?
Molecule trades financial instruments tied to compliance carbon allowances — specifically futures, options, and swaps — rather than the underlying physical credits. The firm does not describe any direct equity or venture-stage company investments on its website; it is a commodities-focused strategy registered with the CFTC.
How does Molecule Ventures source its investment opportunities?
Opportunities arise from the structural design of cap-and-trade systems, not traditional deal sourcing. The firm’s research team models regulatory trajectories, industrial abatement costs, and auction dynamics to identify positions in markets where allowance supply is tightening faster than emissions can be reduced. It does not partner with external GPs in a traditional fund-of-funds sense.
Which carbon markets does Molecule Ventures target?
The firm trades across the steadily expanding universe of liquid compliance carbon and environmental markets, with research coverage explicitly anchored in European carbon markets — notably the EU Emissions Trading System — and North American cap-and-trade programs. It does not disclose whether it participates in voluntary carbon markets or emerging Asian schemes.
How is Gary Claar involved, and what is Claar Advisors?
Gary Claar serves as a strategic advisor to Molecule Ventures, helping navigate carbon-market risks. He simultaneously operates his own family office, Claar Advisors, and previously co-founded the activist hedge fund JANA Partners, where Nik was also a partner. The relationship embeds hedge-fund-style risk discipline into Molecule’s commodity trading approach.
Is Molecule Ventures open to outside capital?
Yes. Molecule has retained Crestwave Capital as a third-party marketing firm to engage prospective investors. The firm explicitly directs interested parties to contact Crestwave — indicating an active fundraising or capital-raising posture — though it discloses no minimum commitment sizes or current fund vehicles.
What is Molecule Ventures’s regulatory status?
Molecule Ventures LLC is registered with the U.S. Commodity Futures Trading Commission (CFTC) as a Commodity Pool Operator and is a member of the National Futures Association (NFA). This registration allows it to operate pooled investment vehicles that trade commodity futures, options, and swaps on behalf of investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: